Details

NameSymbolSector
PIRAMAL PHARMA LIMITEDPPLPHARMAPharmaceuticals
Open
192.88
High
193.79
Low
189.55
Close
190.04
Volume
2050350
Exchange
nse
Time
14/08

Outlook

Score:  

2.5

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Piramal Pharma is  
None
Estimated Stoploss of Piramal Pharma is ₹  
193.79
Piramal Pharma has a  
Bearishℹ
 pattern. 
Formation of  
None
 candle pattern indicates the trend direction of Piramal Pharma is  
Unpredictableℹ
. 

Trend

Piramal Pharma is in  
Downtrendℹ
. 
Price of Piramal Pharma is  
Downℹ
 by  

5

%. 
Target
Buy @ 

188.6

Sell @ 

210.5

Volume

The trade volumes of Piramal Pharma have become  
Deficientℹ
The volume trend for Piramal Pharma is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Piramal Pharma is  

Down

 by  

55.39

% 

Valuation

The current market price of Piramal Pharma is  
Undervaluedℹ

Financials

Balance
The balance sheet of Piramal Pharma is:  

Balanced

Cashflow
Piramal Pharma has  
Poorℹ
 cash flow because there is  

Shortage

 of  

₹ 36cr

. It is  
Downℹ
 by  

121.82

%. 

(*Mar 2025)

49.04% i.e. ₹ 892cr earned in operatingℹ
26.22% i.e. ₹ 477cr spent in investingℹ
24.19% i.e. ₹ 440cr spent in financingℹ
0.55% i.e. ₹ 10cr spent in otherℹ
Piramal Pharma has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 165cr

. It is  
Upℹ
 by  

632.26

%. 

(*Mar 2024)

53.49% i.e. ₹ 1004cr earned in operatingℹ
23.12% i.e. ₹ 434cr spent in investingℹ
22.48% i.e. ₹ 422cr spent in financingℹ
0.91% i.e. ₹ 17cr earned in otherℹ
Income
The income of Piramal Pharma is  

₹ 1992cr

 and  

Loss

 is :  

₹ 100cr

(*Jun 2025)

Piramal Pharma Losses increased by:  

172.99

% and Income is Down by:  

28.76

% 

(*Jun 2025)

The income of Piramal Pharma is  

₹ 2796cr

 and  

Profit

 is :  

₹ 137cr

(*Mar 2025)

Piramal Pharma Profit is up by:  

1153.85

% and Income is Up by:  

26.17

% 

(*Mar 2025)

The income of Piramal Pharma is  

₹ 2216cr

 and  

Loss

 is :  

₹ 13cr

(*Dec 2024)

Piramal Pharma Losses increased by:  

360

% and Income is Down by:  

3.74

% 

(*Dec 2024)

By using this site you agree to the use of cookies to deliver a better site experience.